Use of fluconazole in daily practice: Still room for improvement

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 2, 2001, Pages 303-310

  Natsch, S ^a   Steeghs, M H M ^b   Hekster, Y A ^a   Meis, J F G M ^a,c   Van Der Meer, J W M ^a   Kullberg, B J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EEMLAND HOSPITAL   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; POLYENE; PYRROLE;

ABDOMINAL INFECTION; ARTICLE; BACTERIAL COLONIZATION; CANDIDIASIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG INDICATION; DRUG USE; ESOPHAGUS DISEASE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MEDICAL AUDIT; MEDICAL PRACTICE; MEDICAL SPECIALIST; MENINGITIS; MICROBIOLOGY; OROPHARYNX; PHARMACIST; PNEUMONIA; PRACTICE GUIDELINE; PRESCRIPTION; PROSPECTIVE STUDY; SKIN INFECTION; STANDARD; TEACHING HOSPITAL; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; VAGINITIS;

EID: 0034890507     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/48.2.303     Document Type: Article

References (24)

1. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990
2. Risk factors for fungal infection in patients with malignant hematologic disorders: Implications for empirical therapy and prophylaxis
3. Risk factors for hospital-acquired candidemia. A matched case-control study
4. Azole antifungal agents: Emphasis on new triazoles
5. Oral azole drugs as systemic antifungal therapy
6. Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy
7. Resistance of yeast to azole-derivative anti-fungals
8. Resistance of Candida species to fluconazole
9. The changing pattern of Candida infections: Different species and increased resistance
10. A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion
11. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
12. An analysis of the trends in the use of antifungal drugs and fungal isolates in a UK university hospital
13. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America
14. Current management of fungal infections
15. Treatment and prevention of general mycoses
16. Therapy of invasive fungal infections
17. Optimizing antimicrobial therapy, a method for antimicrobial drug use evaluation
18. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in-vitro-in-vivo correlation data for fluconazole, itraconazole, and Candida infections
19. A randomised trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
20. Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study
21. An audit of the use of antifungal agents
22. Changing physician performance. A systematic review of the effect of continuing medical education strategies
23. Earlier initiation of antibiotic treatment for severe infections after interventions to improve the organization and specific guidelines in the emergency department